Contract notice: Pharmaceutical products Tender in Poland - 38693824
Tender notice from Poland, published on 06 Dec 2019.
Executive Summary
The SAMODZIELNY PUBLICZNY ZAK?AD OPIEKI ZDROWOTNEJ W GARWOLINIE has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Poland. This Tender notice was published on 06 Dec 2019 and is scheduled to close on 17 Jan 2020, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 38693824, while the tender notice number is 578076-2019 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Other Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33615100, 33600000, 33600000, 33615100, 33622300, 33615000, 33622800, 33621400, 33661000, 33661100, 33661200, 33661300, 33661400, 33661500, 33661600, 33661700, 33662000, 33662100, 33670000, 33673000, 33674000, 33675000, 33691200, 33691300, 33692700, 33693000, 33693300, 33696000, 33611000, 33612000, 33613000, 33614000, 33616000, 33617000, 33620000, 33621000, 33621100, 33621200, 33621300, 33622000, 33622100, 33622200, 33622400, 33622500, 33622600, 33622700, 33630000, 33631000, 33631100, 33631200, 33631400, 33631500, 33631600, 33632000, 33632100, 33632300, 33641100, 33641200, 33641300, 33642100, 33642200, 33642300, 33651000, 33651100, 33651200, 33651400, 33651510, 33651520, 33651600, 33632200, 33692800, 33610000, 33692500, 33692210, 33692510, 15882000, 15884000, 33690000 CPV Description: Pharmaceutical products. Insulin. Diuretics. Medicinal products used in diabetes. Agents acting on the renin-angiotensin system. Blood substitutes and perfusion solutions. Medicinal products for the nervous system. Anaesthetics. Analgesics. Antiepileptics. Anti-Parkinson medicinal products. Psycholeptics. Psychoanaleptics. Other nervous system medicinal products. Medicinal products for sensory organs. Ophthalmologicals. Medicinal products for the respiratory system. Medicinal products for obstructive airway diseases. Cough and cold preparations. Antihistamines for systemic use. Anthelmintics. Ectoparasiticides, incl. scabicides, insecticides and repellents. Glucose solutions. Other therapeutic products. Addiction treatment. Reagents and contrast media. Medicinal products for acid related disorders. Medicinal products for functional gastrointestinal disorders. Laxatives. Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents. Vitamins. Mineral supplements. Medicinal products for the blood, blood-forming organs and the cardiovascular system. Medicinal products for the blood and blood-forming organs. Antithrombotic agents. Antihaemorrhagics. Antianaemic preparations. Medicinal products for the cardiovascular system. Cardiac therapy medicinal products. Antihypertensives. Vasoprotectives. Antihaemorrhoidals for topical use. Beta-blocking agents. Calcium channel blockers. Medicinal products for dermatology and the musculo-skeletal system. Medicinal products for dermatology. Antifungals for dermatological use. Emollients and protectives. Antibiotics and chemotherapeutics for dermatological use. Corticosteroids for dermatological use and dermatological preparations. Antiseptics and disinfectants. Medicinal products for the musculo-skeletal system. Anti-inflammatory and anti-rheumatic products. Antigout preparations. Gynaecological anti-infectives and antiseptics. Other gynaecologicals. Sex hormones and modulators of the genital system. Pituitary, hypothalamic hormones and analogues. Corticosteroids for systemic use. Thyroid therapy medicinal products. General anti-infectives for systemic use and vaccines. Antibacterials for systemic use. Antimycotics for systemic use. Antivirals for systemic use. Antisera. Immunoglobulins. Vaccines. Muscle relaxants. Dialysis solutions. Medicinal products for the alimentary tract and metabolism. Injectable solutions. Parenteral feeding solutions. Intravenous fluids. Dietetic products. Baby food. Various medicinal products. Supply of drugs and special medical devices for SP ZOZ in Garwolin Reference Number: OZP / 20/2019 Supply of drugs and special-purpose drugs for SP ZOZ in Garwolin Main Site: Apteka SP ZOZ Garwolin, ul. Lubelska 50 08-400 Garwolin No. International NameDescription of the subject of the order j.m. Number of units 1 Insulinum glulisinum (fast acting analog) solution for injection 100 IU / ml, 3 ml pen 20 2 Insulinum glarginum (insulin analogue with prolonged duration of action) solution for injection 100 IU / ml; 3 ml pre-filled pen 40 3 Insulinum humanum; neutral insulin solution, solution for injection 100 IU / ml; 3 ml pre-filled pen 5 4 Insulinum humanum, biphasic isophane insulin mixture biphasic isophane insulin mixture (25/75) suspension for injection 100 IU / ml and 3 ml pen 5 5 Insulinum humanum; Isophane insulin suspension (long-acting) suspension for injection 100 IU / ml a 3 ml pen 5 Contractors who can apply for the contract: 1) are not subject to exclusion pursuant to art. 24 paragraph1 of the Act and art. 24 paragraph 5 points 1-2, 4-8 of the Public Procurement Law 2) meet the conditions for participating in the proceedings referred to in Art. 22 paragraph 1b of the Act, concerning: - competences or powers to conduct specific professional activities, provided that it results from separate provisions. 1. Current statement as at the date of submission of tenders, indicated by the Employer in the form of a Single European Procurement Document, hereinafter referred to as the "Single Document" referred to in Article 25a (1) of the Public Procurement Law, prepared in accordance with the template of the standard form set out in the Executive Regulation of the European Commission issued on the basis of Article 59 (2) of Directive 2014/24 / EU and Article 80 paragraph 3 of Directive 2014/25 / EU, i.e. Commission Implementing Regulation (EU) 2016/7 of 5 January 2016 establishing a standardthe single European procurement document. The single European procurement document (EAT) must be sent in electronic form with a qualified electronic signature, in accordance with the following rules: ordering by contractors, a single document (EAT) is submitted by each of youcontractors jointly applying for the contract. These documents must confirm compliance with the conditions for participation in the procedure and the absence of grounds for exclusion to the extent that each of the Contractors demonstrates compliance with the conditions for participation in the procedure and no grounds for exclusion. A similar requirement applies to EAT submitted by a subcontractor, pursuant to art. 25a section 5 item 1 of the Public Procurement Law Statement inThe form of the Single European Order Document (EAT) should: - be completed by the Contractor using the provisions of the Public Procurement Office's instructions, which can be found at the following Internet address https://www.uzp.gov.pl/data/assets/pdf_file/0014/ 31361 / JEDZ-instruction.pdf, - be completed using the system available through the website: https://ec.europa.eu/tools/espd/ or via the Marketplanet OnePlace platform via the link: https://spzozgarwolin.ezamawiacy.pl/servlet/HomeServlet or through other available tools or software that allow you to complete the EAT and create an electronic document . NOTE: Submission of EAT together with the offer on a data carrier (e.g. CD, flash drive) is unacceptable, as it is not itssubmission by electronic means of communication within the meaning of the provisions of the Act of 18 July 2002 on the provision of electronic services - contain information necessary to demonstrate the lack of grounds for exclusion - after creating or generating it by the contractor be signed by a qualified electronic signature issued by qualified trust service provider, beingan entity providing certification services - an electronic signature that meets the security requirements set out in the Act of 5 September 2016 on trust and electronic identification services (Journal of Laws of 2016, item 1579) - be submitted in one of the following formats sent data: .pdf, .doc, .docx, .rtf, .xps, .odt, - EAT submitted upon request pursuant to art. 26 section 3 of the ActPublic Procurement Law - does not require encryption, but only an electronic form with a qualified electronic signature. The information contained in the statement will constitute a preliminary confirmation that the Contractor is not subject to exclusion and meets the conditions for participation in the procedure. Part B Statement on belonging or not belonging to a capital group 1 . Contractor, within 3 days of placingvia the Marketplanet OnePlace platform via the link: https://spzozgarwolin.ezamawiacy.pl/servlet/HomeServlet information from the opening of offers, provides the Employer with a declaration of belonging or non-belonging to the same capital group 3. The awarding entity acting pursuant to art. 24 paragraph 5, points 1-2, 4-8 of the Act will exclude Wyko from the public procurement procedurethe applicant: 1) in relation to which liquidation was opened, the arrangement approved by the court in the restructuring proceedings provides for satisfaction of creditors by the liquidation of its assets or the court ordered the liquidation of its assets pursuant to art. 332 paragraph 1 of the Act of 15 May 2015 - Restructuring Law (Journal of Laws of 2015, item 978, as amended) or whose bankruptcy was announced, except forcontractors who, after the declaration of bankruptcy, concluded an arrangement approved by a final court decision, if the arrangement does not provide for satisfaction of creditors by liquidation of the assets of the bankrupt, unless the court ordered the liquidation of its assets pursuant to art. 366 section 1 of the Act of February 28, 2003 - Bankruptcy Law (Journal of Laws of 2015, item 233, as amended); 2) which is grossly infringedprofessional duties, which undermines his integrity, in particular when the contractor as a result of the intended action or gross negligence failed to perform or improperly performed the contract, which the contracting authority is able to demonstrate using appropriate means of evidence; 3) which for reasons attributable to him, has failed to perform or improperly performed a previous contract in a significant mannerpublic works or concession contract concluded with the awarding entity referred to in art. 3 clause 1 points 1-4, which led to the termination of the contract or the award of compensation; 4) being a natural person who has been validly convicted of an offense against the rights of the employee or an offense against the environment, if for committing the sentence the arrest, restriction of liberty or fine has not been imposedless than PLN 3, 000; 5) if an in-office member of his management or supervisory body, a partner in a public or partnership company or a general partner in a limited partnership or limited joint-stock partnership or a commercial proxy, a valid conviction for the offense referred to in point 4; 6) for which a final administrative decision was issued on breach of the obligations arising from the provisiono in labor law, environmental protection law or social security regulations, if this decision was imposed with a financial penalty of not less than PLN 3, 000; 7) who violated obligations regarding taxes, fees or social security or health insurance contributions, which the contracting authority is able to demonstrate by appropriate means of proof, except in the case referred to in Art. 24paragraph. 1 point 15, unless the contractor has made payments of due taxes, fees or social security or health insurance contributions together with interest or fines or has entered into a binding agreement on the repayment of these claims; Internet address (URL): www.spzozgarwolin.pl
The bid deadline for Contract notice: Pharmaceutical products was 17 Jan 2020. Bidding is closed.
This tender has been issued by SAMODZIELNY PUBLICZNY ZAK?AD OPIEKI ZDROWOTNEJ W GARWOLINIE in Poland.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33615100 - Insulin, 33622300 - Diuretics, 33615000 - Medicinal products used in diabetes, 33622800 - Agents acting on the renin-angiotensin system, 33621400 - Blood substitutes and perfusion solutions, 33661000 - Medicinal products for the nervous system, 33661100 - Anaesthetics, 33661200 - Analgesics, 33661300 - Antiepileptics, 33661400 - Anti-Parkinson medicinal products, 33661500 - Psycholeptics, 33661600 - Psychoanaleptics, 33661700 - Other nervous system medicinal products, 33662000 - Medicinal products for sensory organs, 33662100 - Ophthalmologicals, 33670000 - Medicinal products for the respiratory system, 33673000 - Medicinal products for obstructive airway diseases, 33674000 - Cough and cold preparations, 33675000 - Antihistamines for systemic use, 33691200 - Anthelmintics, 33691300 - Ectoparasiticides, incl. scabicides, insecticides and repellents, 33692700 - Glucose solutions, 33693000 - Other therapeutic products, 33693300 - Addiction treatment, 33696000 - Reagents and contrast media, 33611000 - Medicinal products for acid related disorders, 33612000 - Medicinal products for functional gastrointestinal disorders, 33613000 - Laxatives, 33614000 - Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents, 33616000 - Vitamins, 33617000 - Mineral supplements, 33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system, 33621000 - Medicinal products for the blood and blood-forming organs, 33621100 - Antithrombotic agents, 33621200 - Antihaemorrhagics, 33621300 - Antianaemic preparations, 33622000 - Medicinal products for the cardiovascular system, 33622100 - Cardiac therapy medicinal products, 33622200 - Antihypertensives, 33622400 - Vasoprotectives, 33622500 - Antihaemorrhoidals for topical use, 33622600 - Beta-blocking agents, 33622700 - Calcium channel blockers, 33630000 - Medicinal products for dermatology and the musculo-skeletal system, 33631000 - Medicinal products for dermatology, 33631100 - Antifungals for dermatological use, 33631200 - Emollients and protectives, 33631400 - Antibiotics and chemotherapeutics for dermatological use, 33631500 - Corticosteroids for dermatological use and dermatological preparations, 33631600 - Antiseptics and disinfectants, 33632000 - Medicinal products for the musculo-skeletal system, 33632100 - Anti-inflammatory and anti-rheumatic products, 33632300 - Antigout preparations, 33641100 - Gynaecological anti-infectives and antiseptics, 33641200 - Other gynaecologicals, 33641300 - Sex hormones and modulators of the genital system, 33642100 - Pituitary, hypothalamic hormones and analogues, 33642200 - Corticosteroids for systemic use, 33642300 - Thyroid therapy medicinal products, 33651000 - General anti-infectives for systemic use and vaccines, 33651100 - Antibacterials for systemic use, 33651200 - Antimycotics for systemic use, 33651400 - Antivirals for systemic use, 33651510 - Antisera, 33651520 - Immunoglobulins, 33651600 - Vaccines, 33632200 - Muscle relaxants, 33692800 - Dialysis solutions, 33610000 - Medicinal products for the alimentary tract and metabolism, 33692500 - Injectable solutions, 33692210 - Parenteral feeding solutions, 33692510 - Intravenous fluids, 15882000 - Dietetic products, 15884000 - Baby food, 33690000 - Various medicinal products.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 38693824. The purchaser document reference is 578076-2019.
This tender falls under Materials and Products, Agriculture and Foods in Poland. Suppliers in these sectors can track similar Poland tenders using CPV-based alerts.